ELANE inhibits the progression of osteosarcoma via suppressing the CXCL12/CXCR4 axis

Mol Cell Biochem. 2026 Jan 5. doi: 10.1007/s11010-025-05426-5. Online ahead of print.

NO ABSTRACT

PMID:41489769 | DOI:10.1007/s11010-025-05426-5